Código QR (código de barras bidimensional)

Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: a single-arm meta-analysis based on prospective studies

Abstract Background The efficacy of bevacizumab combined with erlotinib (B + E) for the treatment of advanced hepatocellular carcinoma, especially for sorafenib-refractory patients, has been observed and evaluated in several trials. We conducted this single arm meta-analysis to generally assess the...

ver descrição completa

Na minha lista:
Principais autores: Liyun He, Huan Deng, Jun Lei, Fengming Yi, Jine Li, Xiu De Fan, Yiping Wei, Jianjun Xu, Wenxiong Zhang
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2019-03-01
coleção:BMC Cancer
Assuntos:
Meta-analysis
Bevacizumab
Erlotinib
Hepatocellular carcinoma
Sorafenib
Acesso em linha:http://link.springer.com/article/10.1186/s12885-019-5487-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados